Adding Retatrutide to this combination helps offset the significant appetite increase and water retention potential
Diabetic Retinopathy Complications: Patients with a history of diabetic retinopathy should be monitored, as complications have been reported in clinical trials
ej., IL-6, TNF-) despus de una lesin isqumica en una investigacin preclnica
Study Design Type: Phase 2, double-blind, randomized, placebo-controlled study Participants: 338 adults (BMI 30 or BMI 27 with a coexisting condition) Groups: Retatrutide 1 mg, 4 mg, 8 mg, 12 mg (different initial doses 2 or 4 mg) and placebo Duration: 48 weeks (plus 4 weeks follow-up) Administration: subcutaneous, 1x weekly Primary endpoint: percentage change in body weight at week 24 Secondary endpoints: change in weight at week 48, 5%, 10%, 15% weight reduction